C. Varns
Impact in
-
- Lymphoma Diagnosis and Treatment
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 7
-
- Monoclonal and Polyclonal Antibodies Research 4
- Radiopharmaceutical Chemistry and Applications 3
- Co-authors
- A.J. Grillo-López (8 shared papers)Christine A. White (4 shared papers)Brian K. Dallaire (4 shared papers)M. S. Czuczman (2 shared papers)Ronald Levy (2 shared papers)Donald L. Klippenstein (2 shared papers)Jay A. Rosenberg (2 shared papers)Leo I. Gordon (1 shared paper)
- Journals
- Journal of Clinical Oncology (2 papers)Annals of Oncology (2 papers)Current Pharmaceutical Biotechnology (2 papers)Biochemical Society Transactions (1 paper)PubMed (2 papers)
- Partner nations
- United StatesSwitzerland
In The Last Decade
C. Varns
9 papers receiving 2.4k citations
C. Varns's Hit Papers
Peers
Comparison fields: 5 of 81
- Pathology and Forensic Medicine 1.4k
- Genetics 732
- Radiology, Nuclear Medicine and Imaging 929
- Oncology 893
- Immunology 564
Countries citing papers authored by C. Varns
This map shows the geographic impact of C. Varns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Varns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Varns more than expected).
Fields of papers citing papers by C. Varns
This network shows the impact of papers produced by C. Varns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Varns. The network helps show where C. Varns may publish in the future.
Co-authors
The 25 scholars most cited alongside C. Varns, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Treatment of Patients With Low-Grade B-Cell Lymphoma With the Combination of Chimeric Anti-CD20 Monoclonal Antibody and CHOP Chemotherapy Hit paper breakdown → | 1999 | 731 |
| 2 | IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma. Hit paper breakdown → | 1997 | 563 |
| 3 | 1999 | 328 | |
| 4 | Yttrium-90-labeled anti-CD20 monoclonal antibody therapy of recurrent B-cell lymphoma. | 1996 | 289 |
| 5 | Overview of the clinical development of rituximab: first monoclonal antibody approved for the treatment of lymphoma. | 1999 | 252 |
| 6 | 1997 | 217 | |
| 7 | 2000 | 133 | |
| 8 | 2000 | 66 | |
| 9 | 2001 | 18 |
About C. Varns
C. Varns is a scholar working on Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging, Oncology, Molecular Biology and Insect Science, having authored 9 papers that have together received 2.6k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (7 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Radiopharmaceutical Chemistry and Applications (3 papers), CAR-T cell therapy research (2 papers) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (1.4k citations), Genetics (732 citations), Radiology, Nuclear Medicine and Imaging (929 citations), Oncology (893 citations) and Immunology (564 citations). C. Varns has collaborated with scholars based in United States and Switzerland. Frequent co-authors include A.J. Grillo-López, Christine A. White, Brian K. Dallaire, M. S. Czuczman, Ronald Levy, Donald L. Klippenstein, Jay A. Rosenberg, Leo I. Gordon, Mansoor Noorali Saleh and AF LoBuglio. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Current Pharmaceutical Biotechnology, Biochemical Society Transactions and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.